Webinar: Making Sense of Psychedelics

Making Sense of Psychedelics: Where Is the Field and Where Does It Need to Go?

It’s been quite the year so far in psychedelics research! On Tuesday 22 October (9:30am ET, 2.30pm BST, 3.30pm CET) we will be bringing together some leading experts online to help us untangle the issues - and reflect on where the field is now, and where it needs to go.  

Psychedelics show therapeutic promise, but the field faces numerous regulatory and scientific challenges – and the question of how to distinguish between hype and hope. This is an optimal moment to get clarity on these challenges and agree priorities across research and regulation. Join us as we explore a wide range of issues and perspectives as part of an impartial reflection on where the field is now, and where it needs to go. 

Join us online as Niall Boyce chairs a timely discussion with Professor Allan Young, Professor Pim Cuijpers and Dr Florence Butlen-Ducuing about evolving our approach to clinical trials, the intersection with psychotherapy research, regulatory and development implications – and the needs of patients and embedding lived experience across the board.   

You can register for the webinar and submit your questions here: https://bit.ly/iamhrf-psychedelics-webinar
 

Dr Florence Butlen-Ducuing - Speaker

Dr Florence Butlen-Ducuing is a clinical psychiatrist with scientific and regulatory background. She started her career at the teaching hospital in Paris then had the opportunity to work at the European Medicines Agency (EMA) as topic lead in psychiatry. She has recently resumed clinical activities at the teaching hospital with a research interest notably in the  investigation of the use of psychedelics for psychiatric disorders. 

Professor Pim Cuijpers - Speaker

Pim Cuijpers. Ph.D. is professor emeritus of Clinical Psychology at the Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health research institute, Vrije Universiteit Amsterdam, The Netherlands. He is also director of the WHO Collaborating Centre for Research and Dissemination of Psychological Interventions in Amsterdam. He is specialised in conducting randomised controlled trials and meta-analyses on prevention and psychological treatments of common mental disorders across the life span. 

Professor Allan Young - Speaker

Professor Allan Young co-leads the Psychoactive Trials Group at King’s College London, which runs controlled clinical trials with psychedelics and related compounds. He holds the Chair of Mood Disorders and is Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, where he is also Vice-Dean for Academic Psychiatry. Professor Young is the clinical academic lead in the Psychological Medicine and Integrated Care Clinical Academic Group in the South London and Maudsley NHS Trust where he is also a Consultant Psychiatrist and the head of the National Affective Disorders Tertiary Clinic. 

Dr Niall Boyce - Session Chair

Dr Niall Boyce joined Wellcome as Head of Field Building in Mental Health in 2021. He is interested in bringing the mental health community together to identify and focus on specific areas with the potential to improve the lives of people experiencing mental health problems. He studied medicine at Oxford University and subsequently trained on the North London psychiatry rotation. He joined The Lancet as a Senior Editor in 2010 and founded The Lancet Psychiatry as its first Editor-in-Chief in 2014.